Search
forResearch 7 of 33
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- 1094 Discovering hair loss treatments that increase the Wnt/β-catenin signaling pathway by high-throughput screening
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →